Companies in #Highly Potent API

Asymchem is a leading global CDMO providing fully integrated small molecule drug development and manufacturing services from clinical stage to commercialization. Their Dunhua 2 Carbapenem site completed its first FDA inspection in 2026 for continuous manufacturing of an API.